TGFB1 and neoplasm: This is the desired function-blocking activity of anti-αvβ6 and has been observed with whole anti-αvβ6 antibodies that block in vitro migration of αvβ6–positive Detroit 562 human pharyngeal carcinoma cells and inhibit tumor growth in vivo by suppressing TGFβ activation [16], [27].